Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology Recommendations
- 25 January 2014
- journal article
- practice guideline
- Published by Springer Science and Business Media LLC in Annals of Nuclear Medicine
- Vol. 28 (4), 393-403
- https://doi.org/10.1007/s12149-014-0806-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The Use of 18F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario ExperienceJournal of Nuclear Medicine, 2012
- 18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: A randomized controlled trialJournal of Nuclear Cardiology, 2009
- FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0European Journal of Nuclear Medicine and Molecular Imaging, 2009
- Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosisJournal of Nuclear Cardiology, 2009
- Imaging of Inflamed and Vulnerable Plaque in Coronary Arteries with 18F-FDG PET/CT in Patients with Suppression of Myocardial Uptake Using a Low-Carbohydrate, High-Fat PreparationJournal of Nuclear Medicine, 2009
- Imaging myocardial metabolismCurrent Opinion in Biotechnology, 2006
- Positron emission tomography myocardial perfusion and glucose metabolism imagingJournal of Nuclear Cardiology, 2006
- The glucose–fatty acid cycle: a physiological perspectiveBiochemical Society Transactions, 2003
- Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans.JCI Insight, 1987